Author

Ana Garre 1

1 Hospital Universitario de La Princesa, IIS-IP and CIBERehd,Madrid,Spain

BISMUTH QUADRUPLE REGIMEN WITH TETRACYCLINE OR DOXYCYCLINE VERSUS PYLERA<sup>®</sup> AS THIRD-LINE RESCUE THERAPY FOR H. PYLORI INFECTION: A PROSPECTIVE MULTICENTER ANALYSIS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

Olga P Nyssen, Ángeles Pérez-Aísa, Luis Rodrigo-Sáez, Manuel Castro Fernandez, Manuel Pabón-Carrasco, Alma Keko-Huerga, Pilar Mata Romero, Juan Ortuño, Jesús Barrio, J Huguet, Ines Modollel, Noelia Alcaide, Alfredo J. Lucendo, Xavier Calvet, Monica Perona, Barbara Gomez, Blas Gomez Rodriguez, Pilar Varela, Manuel Jiménez-

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EFFECTIVENESS AND SAFETY OF USTEKINUMAB IN ULCERATIVE COLITIS: REAL WORLD EVIDENCE FROM ENEIDA REGISTRY

Maria Chaparro, Ana Garre, Marisa Iborra, Manu Barreiro-de Acosta, María José Casanova, Luisa de Castro, Agnes Fernandez Clotet, Joaquin Hinojosa, Maia Boscá-Watts, David Busquets, Alicia López-García, Rufo H. Lorente, N. Manceñido, Teresa Martinez, David Monfort, José Lázaro Pérez-Calle, Albert Villoria, Teresa Angueira;;

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB FOR THE INDUCTION OF REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

Maria Chaparro Sanchez, M Sierra-Ausin, Francisco Mesonero, Ana Belen Beltran Niclos, Nuria Maroto Arce, Ruth De Francisco Garcia, Miguel Mínguez, Y González-Lama, Manuel Barreiro de Acosta, IGNACIO MARIN, Valle García, David Busquets Casals, Alfredo J. Lucendo, Santiago García, Fernando Bermejo, Ramón Pajares Villarroya, B

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Maria Caldas, Ángeles Pérez-Aísa, Manuel Castro Fernandez, Luis Bujanda, Alfredo J. Lucendo, José M. Huguet, Javier Molina Infante, Luis Fernández Salazar, Juan Ortuño, Manuel Domínguez Cajal, Pedro Almela, Josep M Botargués, Judith Gomez, Cristobal de la Coba, Liliana Pozzati, Merce Barenys, Miguel Fernandez-Bermejo, Javi

EFFECTIVENESS OF SECOND-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Maria Caldas, Ángeles Pérez-Aísa, Manuel Castro Fernandez, Luis Bujanda, Luis Rodrigo, Jorge Perez-Lasala, Jesús Barrio, Angel Lanas, Monica Perona, Blas Jose Gómez-Rodríguez, Ines Modolell, Oscar Nuñez, Rafael Ruiz-Zorrilla, Alain Huerta, Eduardo Iyo, Rosario Antón, Ana Campillo, Ramón Pajares-Villaroya, Fernando Bermejo

Efficacy in second-line regimens in Spain: results from the European Registry on H. pylori management (Hp-EuReg)

María Caldas Álvarez, Maria Angeles Perez Aisa, Manuel Castro Fernández, Luis Bujanda Fernández de Piérola, Alfredo J. Lucendo, Jennifer Hinojosa, Nuria Fernandez Moreno, Luis Ricardo Rodrigo Sáez, Manuel Pabon, Luis Ferrer Barceló, Horacio Alonso Galán, Jorge Pérez Lasala, Javier Molina Infante, Benito Velayos, Jesús Barrio;

Efficacy of first-line regimens in Spain: results from the European Registry on H. pylori management (Hp-EuReg)

María Caldas Álvarez, Mari Ángeles Perez Aisa, Manuel Castro Fernández, Luis Bujanda Fernández de Piérola, Alfredo J. Lucendo, Nuria Fernandez Moreno, Jennifer Hinojosa, Luis Ricardo Rodrigo Sáez, Teresa Romero García, Luis Ferrer Barceló, Horacio Alonso Galán, Jorge Pérez Lasala, Javier Molina Infante, Luis Fernández Salazar;

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, JOSE MANUEL BENITEZ CANTERO, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollon, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emi

Item 1 - 10 / 16
1
2